1. Home
  2. DAWN vs PRGO Comparison

DAWN vs PRGO Comparison

Compare DAWN & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.31

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$10.30

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAWN
PRGO
Founded
2018
1887
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
DAWN
PRGO
Price
$21.31
$10.30
Analyst Decision
Buy
Buy
Analyst Count
10
3
Target Price
$26.00
$19.33
AVG Volume (30 Days)
5.8M
3.5M
Earning Date
05-25-2026
05-29-2026
Dividend Yield
N/A
11.36%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$158,182,000.00
$800,000.00
Revenue This Year
$53.52
N/A
Revenue Next Year
$27.10
$1.02
P/E Ratio
N/A
N/A
Revenue Growth
20.60
N/A
52 Week Low
$5.64
$9.23
52 Week High
$21.40
$28.63

Technical Indicators

Market Signals
Indicator
DAWN
PRGO
Relative Strength Index (RSI) 81.71 32.30
Support Level $6.45 N/A
Resistance Level $21.40 $14.84
Average True Range (ATR) 0.45 0.66
MACD 0.74 -0.20
Stochastic Oscillator 99.21 21.44

Price Performance

Historical Comparison
DAWN
PRGO

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: